Evidence map›Paper›PMID 30529062›Full record

ArticleThe journal of allergy and clinical immunology. In practice

Treatment can be continued for mild cutaneous reactions associated with efavirenz.

Thuraya Isaacs, Reginald Mduzumile Ngwanya, Sipho Dlamini, Jonny Peter, Rannakoe Lehloenya

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?The journal of allergy and clinical immunology. In practice · 2020
    Article
  5. Drug hypersensitivity in HIV infection.Current opinion in allergy and clinical immunology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thuraya IsaacsDivision of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Reginald Mduzumile NgwanyaDivision of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Sipho DlaminiDivision of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa.
Jonny PeterCombined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa; Division of Immunology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Rannakoe LehloenyaDivision of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Combined Drug Allergy Clinic, Groote Schuur Hospital, Cape Town, South Africa. Electronic address: rannakoe.lehloenya@uct.ac.za.
University of Cape Town · ZAGroote Schuur Hospital · ZA

Funding

IMmune-mediated Adverse drug Reactions In African HIV endemic setting (IMARI-SA study)K43TW011178 · FIC · UNIVERSITY OF CAPE TOWN LUNG INSTITUTE · PI PETER, JONATHAN · 2018 to 2022
$648k
FIC NIH HHS K43 TW011178
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesDrug EruptionsFemaleHIV InfectionsHumansMaleAlkynesAnti-HIV AgentsBenzoxazinesCyclopropanesefavirenz

Identifiers

PMID30529062
PMCPMC7045143
OpenAlexW2905139094

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.